ALB and metabolic dysfunction-associated steatohepatitis: Patients from the CHC-SF group have shown lower levels of albumins and PLT in comparison with CHC-NSF, NASH and CG, which is an indicator of the impaired synthetic liver function in the advanced stage of the disease.